Yuchun Lee, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 13,800 shares at $315.42 ($4.4M) on 2023-01-26, disclosed to the SEC on 2023-01-27.
Open-market sale of $4.4M VRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $312.80 | 800 | $250K | 5.7% |
| 2 | $314.10 | 2,621 | $823K | 18.9% |
| 3 | $314.10 | 2,621 | $823K | 18.9% |
| 4 | $314.95 | 579 | $182K | 4.2% |
| 5 | $314.95 | 579 | $182K | 4.2% |
| 6 | $315.42 | 302 |
| $95K |
| 2.2% |
| 7 | $315.42 | 302 | $95K | 2.2% |
| 8 | $316.82 | 1,140 | $361K | 8.3% |
| 9 | $316.82 | 1,140 | $361K | 8.3% |
| 10 | $317.95 | 1,000 | $318K | 7.3% |
| 11 | $319.25 | 478 | $153K | 3.5% |
| 12 | $319.25 | 478 | $153K | 3.5% |
| 13 | $320.25 | 400 | $128K | 2.9% |
| 14 | $320.94 | 680 | $218K | 5.0% |
| 15 | $320.94 | 680 | $218K | 5.0% |
| Total | $316.09 avg | 13,800 | $4.4M | 100% |
| Filing → |
| VRTX | SELL | 2023-01-19 | $1.5M | — | Filing → |
| VRTX | SELL | 2022-04-20 | $1.1M | — | Filing → |
| VRTX | SELL | 2022-04-18 | $1.0M | — | Filing → |